Suchergebnisse - "Cherry, Kim E"

PubPharm (2)

1

Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself

enthalten in: PloS one | 2015

von McCrudden, C. | O'Rourke, M. | Cherry, K. | +14

2

Inhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograft

enthalten in: Molecular cancer therapeutics | 2011

von Senra, J. | Telfer, B. | Cherry, K. | +5

1
[1]